Field Talent Manager Syneos - Commercial - ProdField Talent ManagerAtlanta, GAThe Field Talent Manager supports all aspects of the co-employment agreement to include interviewing and hiring, aligning strategic perspectives, coaching core behaviors, financial and administrative oversight, and all aspects of employment to include performance management solutions. 5-7 years’ minimum pharmaceutical sales management experience or 4 years’ minimum human resources management experience with a strong focus in employee relations, coaching and recruiting.
NewOncology/Hematology Specialist, Pittsburgh Incyte CorporationOncology/Hematology Specialist, PittsburghPittsburgh, PennsylvaniaBy accessing this link you can learn about the types of personal data we collect, how we use it, whether collection and processing is optional, sources of the personal data we process, how it is shared, where it is stored or transferred to, how long we keep it, and contact information for Incyte, Incyte’s data protection officer, and your supervisory authority (if applicable). Through the discovery, development, and commercialization of proprietary therapeutics, Incyte has established a portfolio of first-in-class medicines for patients and a strong pipeline of products in Hematology, Oncology and Inflammation and Autoimmunity.
NewOncology/Hematology Specialist, Chicago South Incyte CorporationOncology/Hematology Specialist, Chicago SouthChicago, Illinois$166,000–$210,000 / yearBy accessing this link you can learn about the types of personal data we collect, how we use it, whether collection and processing is optional, sources of the personal data we process, how it is shared, where it is stored or transferred to, how long we keep it, and contact information for Incyte, Incyte’s data protection officer, and your supervisory authority (if applicable). Through the discovery, development, and commercialization of proprietary therapeutics, Incyte has established a portfolio of first-in-class medicines for patients and a strong pipeline of products in Hematology, Oncology and Inflammation and Autoimmunity.
NewTerritory Manager, Respirtech (Memphis) PhilipsTerritory Manager, Respirtech (Memphis)Memphis, TN$138,000–$158,000 / yearRespirTech's Territory Manager represents the InCourage airway clearance therapy medical device, calling on but not limited to Pulmonologists to support patients with chronic respiratory and neuromuscular conditions on a journey to better breathing. Being an expert on Medicare, Medicaid and private insurance coverage-criteria for InCourage vest therapy, while effectively educating healthcare teams in identifying patients who meet coverage criteria.
Senior Learning Lead, US NeuroPsychiatry Artech LLCSenior Learning Lead, US NeuroPsychiatryLawrenceville, NJ$91–$91.27 / hourThese activities include the design, development and execution of training assets for new hire training, brand updates, selling skills, new product launches, competitive product launches, POA meetings and Field Readiness Meetings. In this role, the Learning Lead will work collaboratively across a fast-paced and complex matrix organization, which includes the Commercialization Teams, the US Field Enablement Team, WW Centre of Excellence, and Enterprise Learning Services.
Medical Representative- (1099 Contractor) CbMedical Representative- (1099 Contractor)Los Angeles, CaliforniaAs an independent 1099 Healthcare App Representative, your role is to visit doctor offices in the Los Angeles area and invite them to join the FUERTE platform. FUERTE is the nation’s fastest-growing healthcare networking app — built by doctors and healthcare professionals.
Healthcare App Representative (1099 Contractor) – Los Angeles Area CbHealthcare App Representative (1099 Contractor) – Los Angeles AreaLos Angeles, California$50–$200 / yearCompensation: $25 per medical office registered (Commission-only; no hourly pay) Location: Los Angeles, CA (field-based; local travel required) About FUERTE: FUERTE is the nation’s fastest-growing healthcare networking app — built by doctors and healthcare professionals. What You’ll Do: As an independent 1099 Healthcare App Representative, your role is to visit doctor offices in the Los Angeles area and invite them to join the FUERTE platform.
Field Reimbursement Manager Syneos - Commercial - ProdField Reimbursement ManagerCharlotte, NCThe FRM will need to collaborate cross functionally with Field Sales, Marketing, Market Access, Public Affairs, State and Government Affairs, Trade and Specialty Pharmacy Accounts while abiding by all corporate and industry policy and procedures. The Field Reimbursement Manager (FRM) will operate as the subject-matter expert on reimbursement, access, and coverage issues affecting the client’s products.
Account Executive - MI Clarity - Indiana-Michigan Caris Life SciencesAccount Executive - MI Clarity - Indiana-MichiganIndianaThe Account Executive – MI Clarity is responsible for driving awareness, adoption, and utilization of MI Clarity, an AI-powered prognostic assay designed to assess both early and late distant recurrence risk in postmenopausal patients with HR-positive/HER2-negative, node-negative early-stage breast cancer. Educate healthcare providers and care teams on the clinical utility, prognostic value, and evidence supporting MI Clarity, including its ability to identify both early and late distant recurrence risk in eligible breast cancer patients.
Specialty Account Manager - IVIG CSI PharmacySpecialty Account Manager - IVIGAustin, TexasCommitted to improving the health and livelihood of our patients, our Specialty Account Manager will partner with our extraordinary team of Pharmacists, Clinicians, and Business Professionals to bring the highest quality treatments, care, and comfort to the patients we serve. Develops territory routing plan and updates regularly to obtain optimal efficiency in servicing customer needs and marketing to new business/customers.
Account Executive - MI Clarity - New England Caris Life SciencesAccount Executive - MI Clarity - New EnglandConnecticutThe Account Executive – MI Clarity is responsible for driving awareness, adoption, and utilization of MI Clarity, an AI-powered prognostic assay designed to assess both early and late distant recurrence risk in postmenopausal patients with HR-positive/HER2-negative, node-negative early-stage breast cancer. Educate healthcare providers and care teams on the clinical utility, prognostic value, and evidence supporting MI Clarity, including its ability to identify both early and late distant recurrence risk in eligible breast cancer patients.
Account Executive - MI Clarity - Miami-Puerto Rico Caris Life SciencesAccount Executive - MI Clarity - Miami-Puerto RicoFloridaThe Account Executive – MI Clarity is responsible for driving awareness, adoption, and utilization of MI Clarity, an AI-powered prognostic assay designed to assess both early and late distant recurrence risk in postmenopausal patients with HR-positive/HER2-negative, node-negative early-stage breast cancer. Educate healthcare providers and care teams on the clinical utility, prognostic value, and evidence supporting MI Clarity, including its ability to identify both early and late distant recurrence risk in eligible breast cancer patients.
Account Executive - MI Clarity - Alabama-Mississippi Caris Life SciencesAccount Executive - MI Clarity - Alabama-MississippiAlabamaThe Account Executive – MI Clarity is responsible for driving awareness, adoption, and utilization of MI Clarity, an AI-powered prognostic assay designed to assess both early and late distant recurrence risk in postmenopausal patients with HR-positive/HER2-negative, node-negative early-stage breast cancer. Educate healthcare providers and care teams on the clinical utility, prognostic value, and evidence supporting MI Clarity, including its ability to identify both early and late distant recurrence risk in eligible breast cancer patients.
Account Executive - MI Clarity - Ohio-Pittsburgh Caris Life SciencesAccount Executive - MI Clarity - Ohio-PittsburghOhioThe Account Executive – MI Clarity is responsible for driving awareness, adoption, and utilization of MI Clarity, an AI-powered prognostic assay designed to assess both early and late distant recurrence risk in postmenopausal patients with HR-positive/HER2-negative, node-negative early-stage breast cancer. Educate healthcare providers and care teams on the clinical utility, prognostic value, and evidence supporting MI Clarity, including its ability to identify both early and late distant recurrence risk in eligible breast cancer patients.
Medical App Representative- 1099 Contractor (Los Angeles Area) CbMedical App Representative- 1099 Contractor (Los Angeles Area)Los Angeles, California$50–$200 / yearJob Title: Medical App Representative (1099 Contractor) – Los Angeles Area Compensation: $25 per medical office registered (Commission-only; no hourly pay) Location: Los Angeles, CA (field-based; local travel required) About FUERTE: FUERTE is the nation’s fastest-growing healthcare networking app — built by doctors and healthcare professionals. What You’ll Do: As an independent 1099 Healthcare App Representative, your role is to visit doctor offices in the Los Angeles area and invite them to join the FUERTE platform.
Account Executive - MI Clarity - Rocky Midwest Caris Life SciencesAccount Executive - MI Clarity - Rocky MidwestColoradoThe Account Executive – MI Clarity is responsible for driving awareness, adoption, and utilization of MI Clarity, an AI-powered prognostic assay designed to assess both early and late distant recurrence risk in postmenopausal patients with HR-positive/HER2-negative, node-negative early-stage breast cancer. Educate healthcare providers and care teams on the clinical utility, prognostic value, and evidence supporting MI Clarity, including its ability to identify both early and late distant recurrence risk in eligible breast cancer patients.
Account Executive - MI Clarity - Texoma Caris Life SciencesAccount Executive - MI Clarity - TexomaTexasThe Account Executive – MI Clarity is responsible for driving awareness, adoption, and utilization of MI Clarity, an AI-powered prognostic assay designed to assess both early and late distant recurrence risk in postmenopausal patients with HR-positive/HER2-negative, node-negative early-stage breast cancer. Educate healthcare providers and care teams on the clinical utility, prognostic value, and evidence supporting MI Clarity, including its ability to identify both early and late distant recurrence risk in eligible breast cancer patients.
Account Executive - MI Clarity - Pacific Northwest Caris Life SciencesAccount Executive - MI Clarity - Pacific NorthwestWashingtonThe Account Executive – MI Clarity is responsible for driving awareness, adoption, and utilization of MI Clarity, an AI-powered prognostic assay designed to assess both early and late distant recurrence risk in postmenopausal patients with HR-positive/HER2-negative, node-negative early-stage breast cancer. Educate healthcare providers and care teams on the clinical utility, prognostic value, and evidence supporting MI Clarity, including its ability to identify both early and late distant recurrence risk in eligible breast cancer patients.
Account Executive - MI Clarity - Florida North-S. Carolina Caris Life SciencesAccount Executive - MI Clarity - Florida North-S. CarolinaFloridaThe Account Executive – MI Clarity is responsible for driving awareness, adoption, and utilization of MI Clarity, an AI-powered prognostic assay designed to assess both early and late distant recurrence risk in postmenopausal patients with HR-positive/HER2-negative, node-negative early-stage breast cancer. Educate healthcare providers and care teams on the clinical utility, prognostic value, and evidence supporting MI Clarity, including its ability to identify both early and late distant recurrence risk in eligible breast cancer patients.
Account Executive - MI Clarity - California South Caris Life SciencesAccount Executive - MI Clarity - California SouthCaliforniaThe Account Executive – MI Clarity is responsible for driving awareness, adoption, and utilization of MI Clarity, an AI-powered prognostic assay designed to assess both early and late distant recurrence risk in postmenopausal patients with HR-positive/HER2-negative, node-negative early-stage breast cancer. Educate healthcare providers and care teams on the clinical utility, prognostic value, and evidence supporting MI Clarity, including its ability to identify both early and late distant recurrence risk in eligible breast cancer patients.